Liven Pharma Limited has announced its first successful export to the Arab region, marking a significant milestone in the company’s growth strategy.
The development was disclosed in a notice to the Pakistan Stock Exchange (PSX) on Thursday.
According to the company, the export order was received last year and has now been completed, paving the way for further expansion into international markets.
In a related move, Liven Pharma revealed last month its intention to raise Rs 200 million through a rights issue aimed at strengthening its financial position and supporting future business growth.
The company will issue 20 million ordinary shares at Rs 10 per share, representing approximately 21.5% of its existing paid-up capital. This translates to 21.496 rights shares for every 100 ordinary shares held by shareholders at the close of the share transfer books.
Incorporated in Pakistan on October 21, 1991 as a private limited company, Liven Pharma became public on April 30, 1992 under the Companies Ordinance, 1984 (now Companies Act, 2017).
Its main business is manufacturing pharmaceuticals and allied products.
Stay Connected with ProPakistani
Get the latest business news, market insights, and economic updates wherever you prefer.
Add ProPakistani to Preferred Sources and see more of our stories in Google Search and Top Stories.
I am highly suspicious about the quality of drugs produced by us. The local doctors have seldom praised the quality of drugs produced here. I wonder if the quality of exported drugs is different. If this is so, it is highly condemnable because you cannot feed the country’s population with ineffective costly medicines and enhance their quality to get dollars.
Excellent job done by the company
Which arab country did Liven pharma export the products?